Olanzapine, Orally Disintegrating Tablets, 20 mg, 30-count bottle, Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada, M9L 1T9
Published May 20, 2015 · Recall initiated: April 7, 2015
Summary
FDA records drug Class III recall D-1081-2015, published May 20, 2015 and initiated April 7, 2015. Recalling firm: Apotex Inc.; Status: Terminated; Reported quantity: 5,352 bottles; Lot: Lot # KL0664, Exp 04/15. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent drug
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Apotex Inc.
- Distributor
- Nationwide
- Lot
- Lot # KL0664, Exp 04/15
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- Canada
Related recalls
- FDAMetformin Hydrochloride Extended-Release Tablets, USP 500 mg, 100 count bottles, Rx Only Manufactured by:June 24, 2020
- FDAEquate Maximum Strength Ranitidine Tablets, USP 150 mg Acid Reducer 130 Tablets Distributed by Wal-MartNovember 20, 2019
- FDAPiperacillin and Tazobactam for Injection, USP 4.5 gram/vial* 10-count Single Use Vials per carton, Rx only,May 23, 2018
- FDAPiperacillin and Tazobactam for Injection, USP 3.375 gram/vial* 10-count Single Use Vials per carton, Rx Only,May 23, 2018
- FDAHydroxocobalamin 1) 1000mcg/mL, 2) 5mg/0.5mL, 3) 5000mcg/0.2mL injection, Fallon Wellness Pharmacy, L.L.C.,May 20, 2015
- FDANITROFURANTOIN MONOHYDRATE/MACROCRYSTALS CAPSULES, 100 mg, 100 count bottle, Rx Only --- Distributed byMay 20, 2015
Questions about this recall
Was Olanzapine, Orally Disintegrating Tablets, 20 mg, 30-count bottle, Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada, M9L 1T9 recalled?
Yes. FDA published recall D-1081-2015 on May 20, 2015. Reported hazard: Subpotent drug
What should I do if I have this product?
Voluntary: Firm initiated · Letter